MHT and Alzheimer Risk: New Evidence for a Critical Window, with Roksana Karim, MD, PhD
Karim discusses secondary findings from the ELITE trial of timing for estradiol initiation, which reveal a notable impact on Aβ biomarkers of Alzheimer disease.